相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug
Maider Ugalde-Arbizu et al.
PHARMACEUTICS (2023)
Cisptatin-cyctooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line
Ivana Predarska et al.
DALTON TRANSACTIONS (2022)
Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy
Albert Yu et al.
BIOSENSORS-BASEL (2022)
Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position
Daniil V. Spector et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
A Comparative Loading and Release Study of Vancomycin from a Green Mesoporous Silica
Georgiana Dolete et al.
MOLECULES (2022)
Mesoporous Silica Nanoparticles Enhance the Anticancer Efficacy of Platinum(IV)-Phenolate Conjugates in Breast Cancer Cell Lines
Ivana Predarska et al.
NANOMATERIALS (2022)
Development of a series of flurbiprofen and zaltoprofen platinum(IV) complexes with anti-metastasis competence targeting COX-2, PD-L1 and DNA
Zuojie Li et al.
DALTON TRANSACTIONS (2022)
Tin-loaded mesoporous silica nanoparticles: Antineoplastic properties and genotoxicity assessment
Pallavi C. Choudante et al.
BIOMATERIALS ADVANCES (2022)
Ultrafast Directional Janus Pt-Mesoporous Silica Nanomotors for Smart Drug Delivery
Paula Diez et al.
ACS NANO (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Antitumor potential of cisplatin loaded into SBA-15 mesoporous silica nanoparticles against B16F1 melanoma cells: in vitro and in vivo studies
Dijana Draca et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2021)
Mesoporous silica nanoparticles as a versatile nanocarrier for cancer treatment: A review
Arezoo Sodagar Taleghani et al.
JOURNAL OF MOLECULAR LIQUIDS (2021)
pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers
Minja Mladenovic et al.
PHARMACEUTICS (2021)
Study of cancer cell cytotoxicity, internalization and modulation of growth factors induced by transferrin-conjugated formulations of metallodrug-functionalized mesoporous silica nanoparticles
Diana Diaz Garcia et al.
MICROPOROUS AND MESOPOROUS MATERIALS (2021)
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Ru(II) Polypyridine Complex-Functionalized Mesoporous Silica Nanoparticles as Photosensitizers for Cancer Targeted Photodynamic Therapy
Johannes Karges et al.
ACS APPLIED BIO MATERIALS (2021)
Mesoporous Silica Nanoparticles for Drug Delivery
Miguel Manzano et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Platinum (IV) Derivatives with Cinnamate Axial Ligands as Potent Agents Against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma Cells
Juraj Zajac et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Multifunctional Silica-Based Nanoparticles with Controlled Release of Organotin Metallodrug for Targeted Theranosis of Breast Cancer
Karina Ovejero Paredes et al.
CANCERS (2020)
Nanoarchitectured Structure and Surface Biofunctionality of Mesoporous Silica Nanoparticles
Ranjith Kumar Kankala et al.
ADVANCED MATERIALS (2020)
Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules
Rafael R. Castillo et al.
PHARMACEUTICS (2020)
A Multi-action PtIVConjugate with Oleate and Cinnamate Ligands Targets Human Epithelial Growth Factor Receptor HER2 in Aggressive Breast Cancer Cells
Hana Kostrhunova et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Autophagy as a decisive process for cell death
Seonghee Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Mesoporous silica nanoparticles functionalized with a dialkoxide diorganotin(IV) compound: In search of more selective systems against cancer cells
Diana Diaz-Garcia et al.
MICROPOROUS AND MESOPOROUS MATERIALS (2020)
Cichorins D-F: Three New Compounds from Cichorium intybus and Their Biological Effects
Muhammad Farooq Khan et al.
MOLECULES (2020)
Oral intake of mesoporous silica is safe and well tolerated in male humans
Emilia Hagman et al.
PLOS ONE (2020)
The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity
Rodolfo Chavez-Dominguez et al.
FRONTIERS IN ONCOLOGY (2020)
Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo
Yan Chen et al.
DALTON TRANSACTIONS (2020)
Mesoporous silica nanoparticles functionalised with a photoactive ruthenium(II) complex: exploring the formulation of a metal-based photodynamic therapy photosensitiser
Younes Ellahioui et al.
DALTON TRANSACTIONS (2019)
Extrapolation of phenolic compounds as multi-target agents against cancer and inflammation
Naresh Kumar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data
Alfred I. Neugut et al.
CLINICAL COLORECTAL CANCER (2019)
Multi-action Pt(IV) anticancer agents; do we understand how they work?
Dan Gibson
JOURNAL OF INORGANIC BIOCHEMISTRY (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen
Mauro Ravera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
New insights towards mesoporous silica nanoparticles as a technological platform for chemotherapeutic drugs delivery
Rafael M. Sabio et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Impact of the mesoporous silica SBA-15 functionalization on the mode of action of Ph3Sn(CH2)6OH
David Edeler et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Anti-tumor platinum (IV) complexes bearing the anti-inflammatory drug naproxen in the axial position
Dina A. Tolan et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2019)
The side effects of platinum-based chemotherapy drugs: a review for chemists
Rabbab Oun et al.
DALTON TRANSACTIONS (2018)
A Carrier-Free Nanostructure Based on Platinum(IV) Prodrug Enhances Cellular Uptake and Cytotoxicity
Jingjie Tan et al.
MOLECULAR PHARMACEUTICS (2018)
Modulation of the mechanism of apoptosis in cancer cell lines by treatment with silica-based nanostructured materials functionalized with different metallodrugs
Diana Diaz-Garcia et al.
DALTON TRANSACTIONS (2018)
Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
Xuejiao Li et al.
BIOINORGANIC CHEMISTRY AND APPLICATIONS (2018)
Pt and Ti Complexes Immobilized onto Mesoporous Silica Microspheres and Their Interaction with Molecules of Biological Interest
Isabel del Hierro et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Novel platinum(IV) complexes conjugated with a wogonin derivative as multi-targeted anticancer agents
Xiaodong Qin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Co-Delivery of Cisplatin Prodrug and Chlorin e6 by Mesoporous Silica Nanoparticles for Chemo-Photodynamic Combination Therapy to Combat Drug Resistance
Wei Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
The Platin-X series: activation, targeting, and delivery
Uttara Basu et al.
DALTON TRANSACTIONS (2016)
Functionalized Mesoporous Silica Nanoparticle with Antioxidants as a New Carrier That Generates Lower Oxidative Stress Impact on Cells
Raymond Ebabe Elle et al.
MOLECULAR PHARMACEUTICS (2016)
SBA-15 mesoporous silica particles loaded with cisplatin induce senescence in B16F10 cells
David Edeler et al.
RSC ADVANCES (2016)
One-pot controllable synthesis of carboxylic group functionalized hollow mesoporous silica nanospheres for efficient cisplatin delivery
Z. Jomeh Farsangi et al.
RSC ADVANCES (2016)
Cisplatin and doxorubicin dual-loaded mesoporous silica nanoparticles for controlled drug delivery
Hanwen Li et al.
RSC ADVANCES (2016)
Platinum(IV) Carboxylate Prodrug Complexes as Versatile Platforms for Targeted Chemotherapy
Jun Xiang Ong et al.
CHIMIA (2015)
Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
Wilma Neumann et al.
CHEMMEDCHEM (2015)
Structural elucidation and molecular docking of ferulic acid from Parthenium hysterophorus possessing COX-2 inhibition activity
Naresh Kumar et al.
3 BIOTECH (2015)
Organotin(IV)-Loaded Mesoporous Silica as a Biocompatible Strategy in Cancer Treatment
Mirna Z. Bulatovic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
Rakesh K. Pathak et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Conjugates of Cisplatin and Cyclooxygenase Inhibitors as Potent Antitumor Agents Overcoming Cisplatin Resistance
Wilma Neumann et al.
CHEMMEDCHEM (2014)
Nonporous silica nanoparticles for nanomedicine application
Li Tang et al.
NANO TODAY (2013)
Mesoporous silica nanoparticles for the improved anticancer efficacy of cis-platin
Chia-Hui Lin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Natural Product Total Synthesis in the Organic Laboratory: Total Synthesis of Caffeic Acid Phenethyl Ester (CAPE), A Potent 5-Lipoxygenase Inhibitor from Honeybee Hives
Mohamed Touaibia et al.
JOURNAL OF CHEMICAL EDUCATION (2011)
Increased understanding of platinum anticancer chemistry
Jan Reedijk
PURE AND APPLIED CHEMISTRY (2011)
Mesoporous Silica Microparticles Enhance the Cytotoxicity of Anticancer Platinum Drugs
Zhimin Tao et al.
ACS NANO (2010)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols
Piwen Wang et al.
PLOS ONE (2010)
COX-2 as a target for cancer chemotherapy
Nilanjan Ghosh et al.
PHARMACOLOGICAL REPORTS (2010)
Cyclooxygenases: structural and functional insights
Carol A. Rouzer et al.
JOURNAL OF LIPID RESEARCH (2009)
Paul Ehrlich's magic bullet concept: 100 years of progress
Klaus Strebhardt et al.
NATURE REVIEWS CANCER (2008)
The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis
Karin Mueller-Decker et al.
MOLECULAR CARCINOGENESIS (2007)
Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation
Bolleddula Jayaprakasam et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Update of the preclinical situation of anticancer platinum complexes: Novel design strategies and innovative analytical approaches
M Galanski et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Reduction of MTT by aqueous herbal extracts in the absence of cells
M Shoemaker et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
A molecular biological study of anti-tumor mechanisms of an anti-cancer agent Oxaliplatin against established human gastric cancer cell lines
M Eriguchi et al.
BIOMEDICINE & PHARMACOTHERAPY (2003)
Characterization of sequence-dependent synergy between ZD1839 ('Iressa') and oxaliplatin
JM Xu et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Contribution of apoptosis in the cytotoxicity of the oxaliplatin-irinotecan combination in the HT29 human colon adenocarcinoma cell line
S Arnould et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Platinum(IV) antitumour compounds: their bioinorganic chemistry
MD Hall et al.
COORDINATION CHEMISTRY REVIEWS (2002)
Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay
R Bruggisser et al.
PLANTA MEDICA (2002)
Modeling and comparison of dissolution profiles
P Costa et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
分享论文
